Transendocardial CD34 Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy

Transendocardial CD34 Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy

We investigated the effects of cell therapy on local mechanical dyssynchrony (LMD) in patients with nonischemic dilated cardiomyopathy (NICM). We analyzed electromechanical data of 30 NICM patients undergoing CD34 + cell transplantation. All patients underwent bone marrow stimulation; CD34 + cells w...

Full description

Bibliographic Details
Main Authors:	Neža Žorž, Gregor Poglajen, Sabina Frljak, Ivan Knezevič, Bojan Vrtovec
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-03-01
Series:	Cell Transplantation
Online Access:	https://doi.org/10.1177/09636897221080384

Similar Items

Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure
by: Gregor Poglajen, et al.
Published: (2019-07-01)

Cell Therapy in Heart Failure with Preserved Ejection Fraction
by: Sabina Frljak, et al.
Published: (2022-03-01)

Restrictive annuloplasty or replacement on reverse remodeling for nonischemic dilated cardiomyopathy
by: Yusuke Misumi, et al.
Published: (2024-04-01)

Parameters of the mitral apparatus in patients with ischemic and nonischemic dilated cardiomyopathy
by: João Presume, et al.
Published: (2023-12-01)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
by: Mark A. Lawson, et al.
Published: (2021-04-01)

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review
by: Cecilie Hoeeg, et al.
Published: (2020-12-01)

Assessment of cardiac dyssynchrony in Nigerian patients with dilated cardiomyopathy
by: Eme Offiah, et al.
Published: (2016-01-01)

Arrhythmogenic Cardiomyopathy
by: Blaž Podgoršek, et al.
Published: (2019-01-01)

Ivabradine Improves Heart Rate Variability in Patients with Nonischemic Dilated Cardiomyopathy
by: Ertugrul Kurtoglu, et al.
Published: (2014-10-01)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
by: Konstantinou, D, et al.
Published: (2014)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy
by: Konstantinou, D, et al.
Published: (2014)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
by: Guliz Kozdag, et al.
Published: (2008-04-01)

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy
by: Bryon A. Tompkins, et al.
Published: (2018-07-01)

Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy.
by: Kristine Yee, et al.
Published: (2014-01-01)

TNF-α Predicts Endothelial Function and Number of CD34<sup>+</sup> Cells after Stimulation with G-CSF in Patients with Advanced Heart Failure
by: Sabina Ugovšek, et al.
Published: (2022-08-01)

Ventricular arrhythmias in nonischemic cardiomyopathy
by: Fa‐Po Chung, et al.
Published: (2018-08-01)

Dyssynchrony Induced by Ventricular Preexcitation: A Risk Factor for the Development of Dilated Cardiomyopathy
by: Chencheng Dai, et al.
Published: (2020-08-01)

Modern treatment methods for heart failure
by: Bojan Vrtovec, et al.
Published: (2011-04-01)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
by: Gregor Poglajen, et al.
Published: (2020-07-01)

Tacrolimus-induced nonischemic dilated cardiomyopathy in a postrenal transplant recipient - A case report
by: Prawash Kumar Chowdhary, et al.
Published: (2022-01-01)

Interventricular mechanical dyssynchrony in dilated cardiomyopathy and its relation with left ventricular systolic dysfunction
by: Ahlam Kadhim Abbood, et al.
Published: (2018-01-01)

Current status of the ICD in nonischemic cardiomyopathy
by: Venkatakrishnan Ramakumar, et al.
Published: (2018-01-01)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
by: Kengo Kusano
Published: (2018-08-01)

Role of cardiac MRI in nonischemic cardiomyopathies
by: Senthil Anand, et al.
Published: (2016-05-01)

Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
by: Farah Cadour, et al.
Published: (2023-02-01)

Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy
by: Keitaro Domae, et al.
Published: (2021-07-01)

Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta‐analysis of randomized controlled trials
by: Avnish Tripathi, et al.
Published: (2021-10-01)

Fragmented narrow QRS complex: Predictor of left ventricular dyssynchrony in non-ischemic dilated cardiomyopathy
by: Jamal Yusuf, et al.
Published: (2013-03-01)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
by: Kenji Okubo, et al.
Published: (2018-08-01)

Sudden cardiac death in patients with nonischemic cardiomyopathy
by: Brian P. Betensky, et al.
Published: (2014-01-01)

Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
by: Huang G, et al.
Published: (2021-09-01)

Diabetes mellitus is associated to high-risk late gadolinium enhancement and worse outcomes in patients with nonischemic dilated cardiomyopathy
by: Pablo Zulet, et al.
Published: (2024-01-01)

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
by: Hyue-Mee Kim, et al.
Published: (2021-04-01)

Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients With Ischemic and Nonischemic Dilated Cardiomyopathy
by: Fang Lin, et al.
Published: (2019-11-01)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
by: Marthe A.J. Becker, et al.
Published: (2020-02-01)

Added value of contrast echocardiography in characterization of nonischemic cardiomyopathy
by: Shufang Pi, et al.
Published: (2018-11-01)

Identification of patients with nonischemic dilated cardiomyopathy at risk of malignant ventricular arrhythmias: insights from cardiac magnetic resonance feature tracking
by: Hai-Yan Ma, et al.
Published: (2024-01-01)

Left Ventricular Geometry and Replacement Fibrosis Detected by cMRI Are Associated with Major Adverse Cardiovascular Events in Nonischemic Dilated Cardiomyopathy
by: Bianca Olivia Cojan-Minzat, et al.
Published: (2020-06-01)

Temporal Changes in Beat‐to‐Beat Variability of Repolarization Predict Imminent Nonsustained Ventricular Tachycardia in Patients With Ischemic and Nonischemic Dilated Cardiomyopathy
by: Matthew Amoni, et al.
Published: (2022-07-01)

The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies
by: Karamitsos, T, et al.
Published: (2013)